These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 36091808)

  • 1. Discovery of genistein derivatives as potential SARS-CoV-2 main protease inhibitors by virtual screening, molecular dynamics simulations and ADMET analysis.
    Liu J; Zhang L; Gao J; Zhang B; Liu X; Yang N; Liu X; Liu X; Cheng Y
    Front Pharmacol; 2022; 13():961154. PubMed ID: 36091808
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Maurya AK; Mishra N
    J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.
    Yadav R; Imran M; Dhamija P; Chaurasia DK; Handu S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6617-6632. PubMed ID: 32715956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of Iminosugars as Antiviral Agents against SARS-CoV-2 Main Protease: Inhibitor Design and Optimization, Molecular Docking, and Molecular Dynamics Studies to Explore Potential Inhibitory Effect of 1-Deoxynojirmycin Series.
    Miglani V; Sharma P; Kumar Narula A
    Curr Comput Aided Drug Des; 2023 Aug; ():. PubMed ID: 37612857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational selection of flavonoid compounds as inhibitors against SARS-CoV-2 main protease, RNA-dependent RNA polymerase and spike proteins: A molecular docking study.
    Rameshkumar MR; Indu P; Arunagirinathan N; Venkatadri B; El-Serehy HA; Ahmad A
    Saudi J Biol Sci; 2021 Jan; 28(1):448-458. PubMed ID: 33110386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic.
    Fakhar Z; Faramarzi B; Pacifico S; Faramarzi S
    J Biomol Struct Dyn; 2021 Oct; 39(16):6171-6183. PubMed ID: 32741312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
    Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
    J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An
    Rangsinth P; Sillapachaiyaporn C; Nilkhet S; Tencomnao T; Ung AT; Chuchawankul S
    J Tradit Complement Med; 2021 Mar; 11(2):158-172. PubMed ID: 33520685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational screening of phytochemicals from three medicinal plants as inhibitors of transmembrane protease serine 2 implicated in SARS-CoV-2 infection.
    Oyedara OO; Agbedahunsi JM; Adeyemi FM; Juárez-Saldivar A; Fadare OA; Adetunji CO; Rivera G
    Phytomed Plus; 2021 Nov; 1(4):100135. PubMed ID: 35403085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel inhibitor of SARS-CoV-2 3CL-PRO through virtual screening and molecular dynamics simulation.
    Bepari AK; Reza HM
    PeerJ; 2021; 9():e11261. PubMed ID: 33954055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target.
    Kundu D; Selvaraj C; Singh SK; Dubey VK
    J Biomol Struct Dyn; 2021 Jun; 39(9):3428-3434. PubMed ID: 32362243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl β-D-galactopyranoside esters as potential inhibitors for SARS-CoV-2 protease enzyme: synthesis, antimicrobial, PASS, molecular docking, molecular dynamics simulations and quantum computations.
    Amin MR; Yasmin F; Dey S; Mahmud S; Saleh MA; Emran TB; Hasan I; Rajia S; Ogawa Y; Fujii Y; Yamada M; Ozeki Y; Kawsar SMA
    Glycoconj J; 2022 Apr; 39(2):261-290. PubMed ID: 35037163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of potent phytochemical inhibitors against SARS-CoV-2 protease and its two Asian mutants.
    Muhammad I; Rahman N; Gul-E-Nayab ; Niaz S; Basharat Z; Rastrelli L; Jayanthi S; Efferth T; Khan H
    Comput Biol Med; 2021 Jun; 133():104362. PubMed ID: 33894500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteolin and abyssinone II as potential inhibitors of SARS-CoV-2: an in silico molecular modeling approach in battling the COVID-19 outbreak.
    Shawan MMAK; Halder SK; Hasan MA
    Bull Natl Res Cent; 2021; 45(1):27. PubMed ID: 33495684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual screening, drug-likeness analysis, and molecular docking study of potential severe acute respiratory syndrome coronavirus 2 main protease inhibitors.
    Nedeljković NV; Nikolić MV; Stanković AS; Jeremić NS; Tomović DL; Bukonjić AM; Radić GP; Mijajlović MŽ
    Turk J Chem; 2022; 46(1):116-146. PubMed ID: 38143877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.
    Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A
    PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target-based drug discovery, ADMET profiling and bioactivity studies of antibiotics as potential inhibitors of SARS-CoV-2 main protease (M
    Abdul-Hammed M; Adedotun IO; Falade VA; Adepoju AJ; Olasupo SB; Akinboade MW
    Virusdisease; 2021 Dec; 32(4):642-656. PubMed ID: 34226871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Inhibitory Potential of Ferulic Acid Derivatives against the SARS-CoV-2 Main Protease: Molecular Docking, Molecular Dynamics, and ADMET Evaluation.
    Antonopoulou I; Sapountzaki E; Rova U; Christakopoulos P
    Biomedicines; 2022 Jul; 10(8):. PubMed ID: 35892687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtual screening, ADMET profiling, PASS prediction, and bioactivity studies of potential inhibitory roles of alkaloids, phytosterols, and flavonoids against COVID-19 main protease (M
    Abdul-Hammed M; Adedotun IO; Olajide M; Irabor CO; Afolabi TI; Gbadebo IO; Rhyman L; Ramasami P
    Nat Prod Res; 2022 Jun; 36(12):3110-3116. PubMed ID: 34107799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.